Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 443 Issue 7113, 19 October 2006

Editorial

  • Advertisement

  • A German exercise to foster élite universities began inauspiciously but is a step in the right direction.

    Editorial
  • A fresh start beckons for the politics of US science.

    Editorial
Top of page ⤴

Research Highlights

Top of page ⤴

News

Top of page ⤴

News in Brief

Top of page ⤴

Correction

Top of page ⤴

Business

  • 'Product Red' is the private sector's bid to fight HIV. But is it too little too late? Colin Macilwain investigates.

    Business
Top of page ⤴

News Feature

  • Can science influence politics in the forthcoming US elections? Nature investigates how Democrats and Republicans are striving to win the hearts of voters.

    • Geoff Brumfiel
    • Meredith Wadman
    • Heidi Ledford
    News Feature
  • Representative Rush Holt is a rare thing in the US Congress — a bona fide scientist building a promising political career. Since his election for the 12th district of New Jersey — the one containing Princeton — eight years ago, this former physicist and son of a West Virginia senator has garnered several powerful committee slots. Holt has emerged as one of the Democratic Party's most prominent spokesmen on science, education and security. Colin Macilwain asked him about the life of a scientist on Capitol Hill, and what the mid-term elections could mean for science and education.

    News Feature
  • Darwin is the latest eminent scientist to get an online archive. How do these undertakings change our understanding of history, asks Henry Nicholls.

    • Henry Nicholls
    News Feature
Top of page ⤴

Correspondence

Top of page ⤴

Commentary

  • To maximize the resources allocated to science and technology during the next US administration the science community must prepare now, argues Thomas Kalil.

    • Thomas Kalil
    Commentary
Top of page ⤴

Books & Arts

Top of page ⤴

News & Views

  • Zeolites are materials with widespread applications. A newly synthesized example has desirably large pores, as well as the virtue of thermal stability, and shows the value of structure-prediction programs.

    • Raul F. Lobo
    News & Views
  • An international consortium of researchers has produced an impressive new tree of life for the kingdom Fungi. The results are a testament to cooperation between systematists with different expertise.

    • Tom Bruns
    News & Views
  • Insulin-degrading enzyme is implicated in diabetes and Alzheimer's disease, but few molecular tools exist that can probe its function. A study now reveals its unusual structure and may lead to an expanded toolbox.

    • Malcolm A. Leissring
    • Dennis J. Selkoe
    News & Views
  • New finds from Gibraltar date Mousterian tools to as recently as 28,000 years ago. By inference, their Neanderthal makers survived in southern Iberia long after all other well-dated occurrences of the species.

    • Eric Delson
    • Katerina Harvati
    News & Views
Top of page ⤴

Brief Communication

  • A single optical fibre acts as a flexible probe to transmit a superior image of an internal landscape.

    • D. Yelin
    • I. Rizvi
    • G. J. Tearney
    Brief Communication
Top of page ⤴

Introduction

Top of page ⤴

Review Article

Top of page ⤴

Article

Top of page ⤴

Letter

Top of page ⤴

Prospects

Top of page ⤴

Movers

Top of page ⤴

Recruiters and Academia

  • Ten steps to master the art of peer review.

    • David A. Mackey
    Recruiters and Academia
Top of page ⤴

Graduate Journal

  • Technology can liberate or enslave graduate students.

    • Katja Bargum
    Graduate Journal
Top of page ⤴

Futures

Top of page ⤴

Authors

Top of page ⤴

Insight

  • The prevalence of neurodegenerative disorders such as Alzheimer's disease and Parkinson's disease is increasing, but effective treatments are lacking. Researchers have revealed many parallels among this diverse group of disorders, including protein aggregation and mitochondrial dysfunction. It is hoped that greater understanding of these processes and their role in disease will lead to new treatments.

    Insight
Top of page ⤴
Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Quick links